Selected research
Industry Research
Loxoprofen API (Sodium Salt) Industry Research Report 2026
Market perspective
The global Loxoprofen API (Sodium Salt) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Loxoprofen API (Sodium Salt) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Loxoprofen API (Sodium Salt) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Loxoprofen API (Sodium Salt) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Loxoprofen API (Sodium Salt) include Anlon Healthcare, Daiichi Sankyo, Metrochem, Shinpoong Pharm, Dongyue Pharma, Hunan Jiudian Hongyang, Luoxin Pharmaceutical, Apeloa Pharmaceutical and Zhejiang Starry Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Loxoprofen API (Sodium Salt) market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Loxoprofen API (Sodium Salt) Market by Company
Anlon Healthcare
Daiichi Sankyo
Metrochem
Shinpoong Pharm
Dongyue Pharma
Hunan Jiudian Hongyang
Luoxin Pharmaceutical
Apeloa Pharmaceutical
Zhejiang Starry Pharmaceutical
Loxoprofen API (Sodium Salt) Segment by Type
Purity ≥99%
Purity<99%
Loxoprofen API (Sodium Salt) Segment by Application
Oral Dosage
External Preparation
Loxoprofen API (Sodium Salt) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loxoprofen API (Sodium Salt) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Loxoprofen API (Sodium Salt) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loxoprofen API (Sodium Salt).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Loxoprofen API (Sodium Salt) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Loxoprofen API (Sodium Salt) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Loxoprofen API (Sodium Salt) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥99%
- Purity<99%
Applications
- Oral Dosage
- External Preparation
Companies covered
- Anlon Healthcare
- Daiichi Sankyo
- Metrochem
- Shinpoong Pharm
- Dongyue Pharma
- Hunan Jiudian Hongyang
- Luoxin Pharmaceutical
- Apeloa Pharmaceutical
- Zhejiang Starry Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Loxoprofen API (Sodium Salt) Market Size (2021-2032)
- 2.2.2 Global Loxoprofen API (Sodium Salt) Sales (2021-2032)
- 2.2.3 Global Loxoprofen API (Sodium Salt) Market Average Price (2021-2032)
- 2.3 Loxoprofen API (Sodium Salt) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity ≥99%
- 2.3.3 Purity<99%
- 2.4 Loxoprofen API (Sodium Salt) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oral Dosage
- 2.4.3 External Preparation
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Loxoprofen API (Sodium Salt) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Loxoprofen API (Sodium Salt) Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Loxoprofen API (Sodium Salt) Revenue of Manufacturers (2021-2026)
- 3.4 Global Loxoprofen API (Sodium Salt) Average Price by Manufacturers (2021-2026)
- 3.5 Global Loxoprofen API (Sodium Salt) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Loxoprofen API (Sodium Salt), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Loxoprofen API (Sodium Salt), Product Type & Application
- 3.8 Global Manufacturers of Loxoprofen API (Sodium Salt), Established Date
- 3.9 Global Loxoprofen API (Sodium Salt) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Anlon Healthcare
- 4.1.1 Anlon Healthcare Company Information
- 4.1.2 Anlon Healthcare Business Overview
- 4.1.3 Anlon Healthcare Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Anlon Healthcare Loxoprofen API (Sodium Salt) Product Portfolio
- 4.1.5 Anlon Healthcare Recent Developments
- 4.2 Daiichi Sankyo
- 4.2.1 Daiichi Sankyo Company Information
- 4.2.2 Daiichi Sankyo Business Overview
- 4.2.3 Daiichi Sankyo Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Daiichi Sankyo Loxoprofen API (Sodium Salt) Product Portfolio
- 4.2.5 Daiichi Sankyo Recent Developments
- 4.3 Metrochem
- 4.3.1 Metrochem Company Information
- 4.3.2 Metrochem Business Overview
- 4.3.3 Metrochem Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Metrochem Loxoprofen API (Sodium Salt) Product Portfolio
- 4.3.5 Metrochem Recent Developments
- 4.4 Shinpoong Pharm
- 4.4.1 Shinpoong Pharm Company Information
- 4.4.2 Shinpoong Pharm Business Overview
- 4.4.3 Shinpoong Pharm Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shinpoong Pharm Loxoprofen API (Sodium Salt) Product Portfolio
- 4.4.5 Shinpoong Pharm Recent Developments
- 4.5 Dongyue Pharma
- 4.5.1 Dongyue Pharma Company Information
- 4.5.2 Dongyue Pharma Business Overview
- 4.5.3 Dongyue Pharma Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Dongyue Pharma Loxoprofen API (Sodium Salt) Product Portfolio
- 4.5.5 Dongyue Pharma Recent Developments
- 4.6 Hunan Jiudian Hongyang
- 4.6.1 Hunan Jiudian Hongyang Company Information
- 4.6.2 Hunan Jiudian Hongyang Business Overview
- 4.6.3 Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Product Portfolio
- 4.6.5 Hunan Jiudian Hongyang Recent Developments
- 4.7 Luoxin Pharmaceutical
- 4.7.1 Luoxin Pharmaceutical Company Information
- 4.7.2 Luoxin Pharmaceutical Business Overview
- 4.7.3 Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
- 4.7.5 Luoxin Pharmaceutical Recent Developments
- 4.8 Apeloa Pharmaceutical
- 4.8.1 Apeloa Pharmaceutical Company Information
- 4.8.2 Apeloa Pharmaceutical Business Overview
- 4.8.3 Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
- 4.8.5 Apeloa Pharmaceutical Recent Developments
- 4.9 Zhejiang Starry Pharmaceutical
- 4.9.1 Zhejiang Starry Pharmaceutical Company Information
- 4.9.2 Zhejiang Starry Pharmaceutical Business Overview
- 4.9.3 Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
- 4.9.5 Zhejiang Starry Pharmaceutical Recent Developments
5 Global Loxoprofen API (Sodium Salt) Market Scenario by Region
- 5.1 Global Loxoprofen API (Sodium Salt) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Loxoprofen API (Sodium Salt) Sales by Region: 2021-2032
- 5.2.1 Global Loxoprofen API (Sodium Salt) Sales by Region: 2021-2026
- 5.2.2 Global Loxoprofen API (Sodium Salt) Sales by Region: 2027-2032
- 5.3 Global Loxoprofen API (Sodium Salt) Revenue by Region: 2021-2032
- 5.3.1 Global Loxoprofen API (Sodium Salt) Revenue by Region: 2021-2026
- 5.3.2 Global Loxoprofen API (Sodium Salt) Revenue by Region: 2027-2032
- 5.4 North America Loxoprofen API (Sodium Salt) Market Facts & Figures by Country
- 5.4.1 North America Loxoprofen API (Sodium Salt) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Loxoprofen API (Sodium Salt) Sales by Country (2021-2032)
- 5.4.3 North America Loxoprofen API (Sodium Salt) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Loxoprofen API (Sodium Salt) Market Facts & Figures by Country
- 5.5.1 Europe Loxoprofen API (Sodium Salt) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Loxoprofen API (Sodium Salt) Sales by Country (2021-2032)
- 5.5.3 Europe Loxoprofen API (Sodium Salt) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Loxoprofen API (Sodium Salt) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Loxoprofen API (Sodium Salt) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Loxoprofen API (Sodium Salt) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Loxoprofen API (Sodium Salt) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Loxoprofen API (Sodium Salt) Market Facts & Figures by Country
- 5.7.1 South America Loxoprofen API (Sodium Salt) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Loxoprofen API (Sodium Salt) Sales by Country (2021-2032)
- 5.7.3 South America Loxoprofen API (Sodium Salt) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Loxoprofen API (Sodium Salt) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Loxoprofen API (Sodium Salt) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Loxoprofen API (Sodium Salt) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Loxoprofen API (Sodium Salt) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Loxoprofen API (Sodium Salt) Sales by Type (2021-2032)
- 6.1.1 Global Loxoprofen API (Sodium Salt) Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Loxoprofen API (Sodium Salt) Sales Market Share by Type (2021-2032)
- 6.2 Global Loxoprofen API (Sodium Salt) Revenue by Type (2021-2032)
- 6.2.1 Global Loxoprofen API (Sodium Salt) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Loxoprofen API (Sodium Salt) Revenue Market Share by Type (2021-2032)
- 6.3 Global Loxoprofen API (Sodium Salt) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Loxoprofen API (Sodium Salt) Sales by Application (2021-2032)
- 7.1.1 Global Loxoprofen API (Sodium Salt) Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Loxoprofen API (Sodium Salt) Sales Market Share by Application (2021-2032)
- 7.2 Global Loxoprofen API (Sodium Salt) Revenue by Application (2021-2032)
- 7.2.1 Global Loxoprofen API (Sodium Salt) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Loxoprofen API (Sodium Salt) Revenue Market Share by Application (2021-2032)
- 7.3 Global Loxoprofen API (Sodium Salt) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Loxoprofen API (Sodium Salt) Value Chain Analysis
- 8.1.1 Loxoprofen API (Sodium Salt) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Loxoprofen API (Sodium Salt) Production Mode & Process
- 8.2 Loxoprofen API (Sodium Salt) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Loxoprofen API (Sodium Salt) Distributors
- 8.2.3 Loxoprofen API (Sodium Salt) Customers
9 Global Loxoprofen API (Sodium Salt) Analyzing Market Dynamics
- 9.1 Loxoprofen API (Sodium Salt) Industry Trends
- 9.2 Loxoprofen API (Sodium Salt) Industry Drivers
- 9.3 Loxoprofen API (Sodium Salt) Industry Opportunities and Challenges
- 9.4 Loxoprofen API (Sodium Salt) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst